Delcath Systems Inc. (DCTH)
DCTH trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/0001628280-26-012019-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | DCTH on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000872912 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $85.2M |
| Net income | $2.7M |
| Operating income | $660K |
| Net margin | 3.2% |
| Operating margin | 0.8% |
| Revenue growth | +129.1% |
| Cash | $43.5M |
| Total assets | $123.6M |
| P/E (computed) | 256.0× |
| P/S (computed) | 8.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-09 |
| Cash and burn | $55.5M cash; operating cash flow $5.7M a quarter. | Report 2026-09-30 |
| Shares outstanding | 34,788,068 (2026-10-30); 35,313,718 a year earlier; 22,046,101 three years earlier. | Cover page 2026-10-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | CBIZ CPAs P.C., New York, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-03-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $287K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $35.1M | $7.0M | $8.2M | $55.5M | No debt tags | $110.0M | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | $29.1M | $2.7M | $5.7M | $47.5M | No debt tags | $95.4M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $25.0M | -$1.1M | $857K | $41.3M | No debt tags | $90.4M | 10-Q 2026-05-07 |
| Q4 2025 2025-12-31 | $20.7M | -$1.9M | $8.2M | $43.5M | No debt tags | $85.2M | 10-K 2026-02-26 |
| Q3 2025 2025-09-30 | $20.6M | $830K | $4.8M | $41.8M | No debt tags | $79.6M | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | $24.2M | $2.7M | $7.3M | $34.4M | No debt tags | $70.2M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $19.8M | $1.1M | $2.2M | $12.8M | No debt tags | $53.9M | 10-Q 2026-05-07 |
| Q4 2024 2024-12-31 | $15.1M | -$3.4M | -$1.0M | $32.4M | $0 | $37.2M | 10-K 2026-02-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2024-09-26 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report | 8-K | 2026-11-09 |
| Latest proxy | DEFA14A | 2026-04-02 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +37.6% |
| 1 month | +34.1% |
| 3 months | +18.4% |
| Year to date | +103.5% |
| 1 year | +138.7% |
| From 52-week high | -5.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SENS | Senseonics Holdings Inc. | $10.90 | +3.02% | $597.1M |
| TCMD | Tactile Systems Technology Inc. | $26.37 | -1.64% | $590.7M |
| SGHT | Sight Sciences Inc. | $10.59 | -2.22% | $588.6M |
| KIDS | OrthoPediatrics Corp. | $31.50 | -2.63% | $822.5M |
| BBNX | Beta Bionics Inc. | $15.21 | -7.37% | $826.9M |
| BVS | Bioventus Inc. | $10.46 | -1.88% | $881.4M |
| AORT | Artivion Inc. | $18.47 | -3.30% | $901.1M |
| ANGO | AngioDynamics Inc. | $11.78 | -0.76% | $495.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier